BIOLEGEND INC REAGENTS COVID-19 PURCHASE

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Limited purpose

Discover comparable awards, related contractors, and agency purchasing history.

Same agency and NAICS · 75A50126F61015 — FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICA… · Department of Health and Human Services · $42,769,479
Same agency and NAICS · 75A50126F61014 — MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS) · Department of Health and Human Services · $2,148,912
Same agency and NAICS · 75N98026P00928 — NHGRI: SUPPLY: SEQUENCING REAGENTS: N/A · Department of Health and Human Services · $346,907
Same agency and NAICS · 75D30126C21514 — FRESH TURKEY, CHICKEN, GUINEA PIG, AND HORSE RED BLOOD CELLS EO14398 · Department of Health and Human Services · $288,194
Same agency and NAICS · 75N98026P00914 — THE INDI PROJECT IS A LARGE-SCALE GENOME ENGINEERING EFFORT EMBEDDED WITHIN CARD TO GENERATE DISEASE-RELEVA… · Department of Health and Human Services · $248,906
Same agency and NAICS · 75N98026P01001 — XOME ENRICHMENT AND SEQUENCING REGENTS ARE REQUIRED FOR WHOLE-EXOME SEQUENCING TO IDENTIFY UNCOMMON AND RAR… · Department of Health and Human Services · $109,676